Labour and Delivery 1.


Bastek JA, Srinivas SK, Sammel MD, et al., Do neonatal outcomes differ depending onnthe cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia, Am J Perinatol, 2010;27:163–9.


2. EXPRESS group; Fellman V, Hellström-Wesdtas L, Norman M, et al., One-year survival of extremely prterem infants after active perinatal care in Sweden, JAMA, 2009;301:2225–33.


3. 4.


Bauer M, Fast C, Haas J, et al., Cystic periventricuklar leukomalacia in preterm infants: an analysis of obstetric risk factors, Early Hum Dev, 2009;85:163–9.


Van De Water M, Kessel ET, et al., Tocoloytic effectiveness of nifedipinje versus ritodrine and follow- up of newborns: a randomised controlled trial, Acta Obstet Gynecol Scand, 2008;87:340–45.


5.


Laros RK, Kitterman JA, Heilbron DC, et al., Outcome of very -low-birth-weight infants exposed to betasympatomimetics in utero, Am J Obstet Gynecol, 1991;164:1657–64.


6.


Neri I, Monari F, Valensise H, et al., Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine, Am J Perinatol, 2009;26:259–63.


7. The Canadian Preterm, labour investigators group, Treatment of preterm labor with the beta-adrenergic


11. 12. 13. 14. agonist rotodrine, N Engl J Med, 1992;327:308–12. 8.


Kurtoglu S, Akcakus M, Keskin M, et al., Severe hyperinsulinaemic hypoglyclaemia in a baby born to a mother taking oral ritodrine therapy for preterm labour, Horm Res, 2005;64:61–3.


9. 10.


Takanashi R, Yamada M, Takahashi T, et al., Risk factors for cerebral palsy in prterm infants, Early Hum Dev, 2005;81:545–53.


Weintraub Z, Solovechick M, Reichman B, et al., Isreal Neonatal Network. Effect of maternal tocolysis on the incidence of severe periventricuolar/intraventricular haemorrhage in very low birthweight infants, Arch Dis Child Fetal Neonatal Ed, 2001;85:F13–17.


Ozcan T, Turan C, Ekici E, et al., Ritodrine tocolysis and neonatal intraventricuolar – periventricuolar hemorrhage, Gynecol Obstet Invest, 1995;39:60–62.


Amin SB, Sinkin RA, Glantz JC, Metanalysis of the effect of antenatal indomethacin on neonatal outcomes, Am J Obstet Gynecol, 2007;197:486.e1–10.


Doyle NM, Gardner MO, Wells L, et al., Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis, J Perinatol, 2005;25:336–40.


Scheepers RC, Bloemenkamp KW, Bolte A, et al., Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II tral), BMC Pregnancy Childbirth, 2009;9:42.


20. 21. 17. 18. 15.


de Heus R, Mulder EJ, Derks JB, et al., The effects of the tocolytics atosiban and nifedipinhe on fetal movements, heart rate and blood flow, J Matern Fetal Neonatal Med, 2009;22:485–90.


16.


Nguon B, Zupan-Simunek V, Audibert F, et al., Tocolysis with calcium – channel blockers and intraventricular hemorrhage, J Gynecol Obstet Biol Reprod (Paris), 2007;36:287–92.


King JF, Flenady VJ, Papatsonis DN, et al., Calcium channel blockers for inhibiting preterm labour, Cochrane Database Syst Rev, 2003;(1):CD002255.


Doyle LW, Crowther CA, Middleton P, et al., Antenatal magnesiumsulfate and neurologic outcome in preterm infants: a systematic review, Obstet Gynecol, 2009;113: 1327–33.


19.


Yokoyama K, Takahashi N, Yada Y, et al., Prlonged maternal magnesium administration and bone metabolism in neonates, Early Hum Dev, 2010;86: 187–91.


Wedig KE, Kogan J, Schorry EK, et al., Skeletal demineralization and fractures caused by fetal magnesium toxicity, J Perinatol, 2006;26:371–4.


Papatsonis D, Flenady V, Liley H, Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour, Cochrane Database Syst Rev, 2009;(1):CD005938.


38


EUROPEAN OBSTETRICS & GYNAECOLOGY


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68